InvestorInvesting in private markets for over 30 years.

LYFE Capital is a healthcare investment platform focused on critical healthcare supply chain assets and next-generation R&D services. With offices in Asia and the U.S., it aims to leverage cross-border opportunities in the healthcare sector.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
LYFE Capital, founded in 2015 by James Zhao, is a healthcare investment platform with a global presence across five offices in Asia and the United States. The organization specializes in investing in critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services. LYFE Capital's mission is to facilitate significant and resilient revenue growth from mature global markets by building meaningful positions in high-growth potential leaders within the healthcare ecosystem. The firm emphasizes geographic revenue expansion and bolt-on acquisitions, leveraging Asia's cost benefits alongside U.S. innovation. With a strategic portfolio of 108 investments, LYFE Capital has a strong track record in the healthcare sector, including notable companies like Cytek Biosciences and Burning Rock.
LYFE Capital invests in healthcare companies that are pivotal to the global healthcare ecosystem. The organization emphasizes building substantial positions in high-growth potential leaders, with a strategy that includes geographic revenue expansion and bolt-on acquisitions. This approach allows LYFE Capital to capitalize on the strengths of both Asian markets and U.S. innovation.
LYFE Capital adds value to its portfolio companies through strategic guidance in geographic expansion, operational efficiencies, and leveraging cross-border synergies between Asian and U.S. markets. The firm’s deep industry expertise and extensive network facilitate growth and innovation within its investments.
LYFE Capital focuses on healthcare companies that are pivotal to the global healthcare ecosystem, emphasizing high-growth potential and the ability to navigate complex regulatory environments.
Founders can pitch to LYFE Capital by sending an email to newlp@lyfecapital.com. It is advisable to include a detailed business plan and financial projections in the pitch.
LYFE Capital differentiates itself through its focus on cross-border opportunities between Asia and the U.S., leveraging unique market advantages to drive growth in healthcare investments.
LYFE Capital invests globally, with a strong emphasis on North America and Asia, allowing them to tap into diverse healthcare markets and innovations.
LYFE Capital provides strategic guidance in geographic expansion, operational efficiencies, and leveraging cross-border synergies, actively supporting portfolio companies in their growth journeys.
LYFE Capital has a total fund size of $2 billion, with investments made across various stages, including pre-seed to Series C, although specific check sizes are not publicly disclosed.
Superscout Pro
Is this page right?Reviewed · How the research works